CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to IPH.PA

IPH5201 + durvalumab + standard chemotherapy

Phase 2
INNATE PHARMA (IPH.PA)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Jun '27
IPH.PAPhase 2

IPH5201 + durvalumab + standard chemotherapy Phase 2 Est. Readout

IPH5201 + durvalumab + standard chemotherapy
Jun 2027~
CT.gov
00%
Drug Information

Target Indication

Non Small Cell Lung Cancer

Clinical Trial

NCT05742607

Last updated: 10/21/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.